3 Reasons to Sell This Pharmacy

Today, Austin discusses three reasons for investors to consider selling Walgreen (NYS: WAG) . The Express Scripts fallout continues to plague the company, creating a gap in the bottom line larger than many investors originally thought. In addition, Walgreen struggles to keep up with the competition. CVS, with its own PBM and more modernized stores, beats Walgreen on a number of counts, while grocery stores and broad-line retailers such as Wal-Mart eat up even more market share. Finally, Austin hates the company's $6.7 billion acquisition of Alliance Boots, which he suggests could be even bigger if they decide to purchase the remaining 55% in a few years.

If you're interested in some of these dividends on your quest for high-yielding stocks, The Motley Fool has compiled a special free report outlining our nine top dependable dividend-paying stocks. It's called "Secure Your Future With 9 Rock-Solid Dividend Stocks." You can access your complimentary copy today at no cost! Just click here to discover the winners we've picked.

The article 3 Reasons to Sell This Pharmacy originally appeared on Fool.com.

Austin Smith owns shares of SUPERVALU. The Motley Fool owns shares of Express Scripts and SUPERVALU. Motley Fool newsletter services recommend Express Scripts. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.